AI-Driven Biomarkers and Early Cancer Detection: Where Multi-Cancer Blood Tests Stand in 2026
How AI-driven biomarkers power multi-cancer early detection blood tests, what PATHFINDER 2 and NHS-Galleri showed, 2026 FDA status and what is unproven.
How AI-driven biomarkers power multi-cancer early detection blood tests, what PATHFINDER 2 and NHS-Galleri showed, 2026 FDA status and what is unproven.